Series A Capital Raise in the biotech sector. Biotechs are notorious for needing massive fund dollars and offer a long road to revenue. But how is the opportunity valued when the opposite is true?
Boston BioPharm is a fully integrated science-driven pharmaceutical/OTC, medical food, and dietary ingredient development company. They offer technology that makes dietary ingredients bioavailable, backed by research that proves they are safe.
In terms of strategy, our challenge was taking a small company playing in a massive sector with no existing brand, and presenting them and their experience in convincing fashion.
Our work has helped executives leaders on six of the seven continents. (We’re still holding out for Antarctica.)